Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 4Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma 7Lymphoma, Large B-Cell, Diffuse 6Multiple Myeloma 5Lymphoma, Non-Hodgkin 5Lymphoma, Extranodal NK-T-Cell 5Hodgkin Disease 5Recurrence 4Neuroblastoma 4Lymphoma, T-Cell, Cutaneous 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Lymphocytic, Chronic, B-Cell 4Leukemia 4Burkitt Lymphoma 4Waldenstrom Macroglobulinemia 3Testicular Neoplasms 3Sezary Syndrome 3Neuroectodermal Tumors, Primitive, Peripheral 3Mycosis Fungoides 3Lymphoma, T-Cell, Peripheral 3Lymphoma, Large-Cell, Anaplastic 3Leukemia, Myeloid, Acute 3Leukemia, Hairy Cell 3Dendritic Cell Sarcoma, Interdigitating 3Central Nervous System Neoplasms 3Teratoma 2Sarcoma 2

Interventions

Proton Therapy 2etoposide phosphate 1Ursodeoxycholic Acid 1Thiotepa 1Resistance Training 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Radiation 1Physical Therapy Modalities 1Paclitaxel 1Mesna 1Melphalan 1Leukapheresis 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Etoposide 1Carboplatin 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Rhabdomyosarcoma × Etoposide × Clear all
NCT01505569 2024-02-26

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

Masonic Cancer Center, University of Minnesota

Phase NA Completed
44 enrolled
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Brain Neoplasms, Carcinoma, Renal Cell, Medulloblastoma, Neoplasms, Germ Cell and Embryonal, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡